Immunosupressió. : Pharmacology of immunosuppression / Howard J. Eisen, editor
2022
1
Immunotaxonomy. : Toward precision medicine : building a knowledge network for biomedical research and a new taxonomy of disease / Committee on a framework for developing a new taxonomy of disease ; Board on Life Sciences ; Division on Earth and Life Studies
Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection
Active immunization where vaccine is administered for therapeutic or preventive purposes. This can include administration of immunopotentiating agents such as BCG vaccine and Corynebacterium parvum as well as biological response modifiers such as interferons, interleukins, and colony-stimulating factors in order to directly stimulate the immune system
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Immunotherapy Breast Cancer : Principles of immunotherapy breast and gastrointestinal cancers : activity, mechanisms of resistance and new sensitization strategies / edited by Michele Ghidini
Immunotherapy Cancer Research : Successes and Challenges of NK Immunotherapy : Breaking Tolerance to Cancer Resistance
2021
1
Immunotherapy Colon (Anatomy) Cancer : Immune therapy for pancreatic and colon cancers / edited by Ganji Purnachandra Nagaraju, Soumya Dakshinamurthy, Sarfraz Ahmad
2025
1
Immunotherapy -- Complications. : Managing immunotherapy related organ toxicities : a practical guide / Yinghong Wang, editor
2022
1
Immunotherapy -- Congresses : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors
Immunotherapy -- ethics : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
Immunotherapy. : A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy
2024
1
Immunotherapy Genitourinary organs Cancer : Neoadjuvant immunotherapy treatment of localized genitourinary cancers : multidisciplinary management / Andrea Necchi, Philippe E. Spiess, editors
